Feasibility and safety of self-expandable metal stent in nonmalignant disease of the lower gastrointestinal tract

In recent years,self-expandable metal stents(SEMSs)have been employed to treat benign gastrointestinal strictures secondary to several conditions:Acute diverticulitis,radiation colitis,inflammatory bowel disease(IBD),and postanastomotic leakages and stenosis.Other applications include endometriosis and fistulas of the lower gastrointestinal tract.Although it may be technically feasible to proceed to stenting in the aforementioned benign diseases of the lower gastrointestinal tract,the outcome has been reported to be poor.In fact,in some settings(such as complicated diverticulitis and postsurgical anastomotic strictures),stenting seems to have a limited evidence-based benefit as a bridge to surgery,while in other settings(such as endometriosis,IBD,radiation colitis,etc.),even society guidelines are not able to guide the endoscopist through decisional algorithms for SEMS placement.The aim of this narrative paper is to review the scientific evidence regarding the use of SEMSs in nonmalignant diseases of the lower gastrointestinal tract,both in adult and pediatric settings.

Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease

BACKGROUND Acute severe lower gastrointestinal bleeding(LGIB)is an uncommon but challenging complication of Crohn’s disease(CD).AIM To identify the predictors of acute severe LGIB and to evaluate the impact of acute severe LGIB on the subsequent clinical course in CD patients.METHODS A retrospective inception cohort study was conducted in 75 CD patients with acute severe LGIB and 1359 CD patients without acute severe LGIB who were diagnosed between February 1991 and November 2019 at Asan Medical Center,a tertiary university hospital in Korea.Multivariable analysis with Cox proportional hazard regression was performed to identify the risk factors for acute severe LGIB.A matched analysis using 72 patients with bleeding and 267 matched patients without within the cohort was also conducted to investigate whether acute severe LGIB is a predictor of clinical outcomes of CD.RESULTS Multivariable Cox regression analysis revealed that early use of thiopurines[hazard ratio(HR):0.23,95%confidence interval(CI):0.12-0.48;P<0.001]and female sex(HR:0.51,95%CI:0.27-0.94;P=0.031)were significantly associated with a lower risk of acute severe LGIB.The cumulative risks of behavioral progression and intestinal resection were not significantly different between the two matched groups(P=0.139 and P=0.769,respectively).The hospitalization rate was higher in the bleeding group than in the matched non-bleeding group(22.1/100 vs 13.2/100 patient-years;P=0.012).However,if hospitalizations due to bleeding episodes were excluded from the analysis,the hospitalization rate was not significantly different between the bleeding group and the matched nonbleeding group(14.5/100 vs 13.2/100 patient-years;P=0.631).CONCLUSION Early use of thiopurines may reduce the risk of acute severe LGIB.History of acute severe LGIB may not have a significant prognostic value in patients with CD.

Gastrointestinal Behcet's disease:A review

Beh?et's disease(BD) is an idiopathic, chronic, relapsing, multi-systemic vasculitis characterized by recurrent oral and genital aphthous ulcers, ocular disease and skin lesions. Prevalence of BD is highest in countries along the ancient silk road from the Mediterranean basin to East Asia. By comparison, the prevalence in North American and Northern European countries is low. Gastrointestinal manifestations of Beh?et's disease are of particular importance as they are associated with significant morbidity and mortality. Although ileocecal involvement is most commonly described, BD may involve any segment of the intestinal tract as well as the various organs within the gastrointestinal system. Diagnosis is based on clinical criteria- there are no pathognomonic laboratory tests. Methods for monitoring disease activity on therapy are available but imperfect. Evidence-based treatment strategies are lacking. Different classes of medications have been successfully used for the treatment of intestinal BD which include 5-aminosalicylic acid, corticosteroids, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody therapy. Like inflammatory bowel disease, surgery is reserved for those who are resistant to medical therapy. A subset of patients have a poor disease course. Accurate methods to detect these patients and the optimal strategy for their treatment are not known at this time.

Appendiceal bleeding:A case report

BACKGROUND Acute lower gastrointestinal bleeding is common in clinical practice,and the colon is responsible for the majority of cases.However,appendiceal bleeding is an extremely rare cause.Appendiceal bleeding due to vascular diseases,such as angiodysplasia and Dieulafoy’s lesion,may result in massive lower gastrointestinal bleeding.Appendectomy is a reliable and effective option for treatment.CASE SUMMARY A 32-year-old male presented to our hospital with hematochezia that had lasted for 6 h,with approximately 600-800 m L bloody stools and loss of consciousness for a few seconds.Persistent bleeding from the orifice of the appendix was observed by colonoscopy.Following the new diagnosis of appendiceal bleeding,the patient was treated by an emergency laparoscopic appendectomy.Finally,the patient was pathologically diagnosed with appendiceal Dieulafoy’s lesion.The patient was uneventfully discharged,and follow-up 2 wk later showed no evidence of rebleeding.CONCLUSION Although appendiceal bleeding is a rare cause of acute lower gastrointestinal bleeding,clinicians should consider it during differential diagnosis.

Application of deep learning in lower gastrointestinal diseases

Deep learning has made tremendous progress in diagnosis assistance and prognosis prediction along with the accumulation of abundant medical data and the improvement of computer algorithms.Many studies have focused on applying deep learning to diseases of the lower gastrointestinal tract.Studies on deep learning and digestive system diseases mainly focus on cancer and inflammatory diseases,while few studies focus on other diseases.In order to better understand the emerging interdisciplinary,this paper reviews the ways in which deep learning may help doctors make a diagnosis or establish a prognosis,revealing that further randomized controlled studies and deeper cooperation between artificial intelligence engineers and doctors will be required.